Abstract
Colorectal cancer is a third rank malignant cancer in Indonesia, generally caused by the diet of the Indonesian people who have change with the consumption of food with high fat and low in fiber, also due to the production of carcinogenic substances from the breakdown of fat. In the condition of colorectal cancer there is overexpression of COX-2 and inhibition of Caspase-3 which causes the increase of cancer cells survival and causes inhibition of apoptosis mechanism. Quercetin is one of flavonoid which known have activity as an antitumor and tested in vitro can induce apoptosis on WiDr colorectal cancer cells . The purpose of this study was to determine the affinity and mechanism of quercetin compounds on COX-2 and Caspase-3 target proteins as colorectal anticancer by in silico with molecular docking. The study was conducted exploratively with the stages of preparing a database of 3D quercetin structures, as well as COX-2 and Caspase-3 proteins, optimization of 3D quercetin structure, protein preparation, molecular docking method validation, and quercetin docking on these proteins. Docking results were assessed from the binding energy and hydrogen bonds that formed between quercetin with proteins. The smaller binding energy value, the stronger the bond between quercetin and proteins is. The results showed that quercetin had an activity as a colorectal anticancer because it was able to inhibit COX-2 and induce Caspase-3 with binding energy values of -9.54 and -4.59. These results showed that quercetin has the potential to induce apoptosis in colorectal cancer. 
 Keywords: colorectal cancer, quercetin, caspase-3, in silico
Highlights
Colorectal cancer is a third rank malignant cancer in Indonesia, generally caused by the diet of the Indonesian people who have change with the consumption of food with high fat and low in fiber, due to the production of carcinogenic substances from the breakdown of fat
The results showed that quercetin had an activity as a colorectal anticancer because it was able to inhibit COX-2 and induce Caspase-3 with binding energy values of -9.54 and -4.59
These results showed that quercetin has the potential to induce apoptosis in colorectal cancer
Summary
Program Studi Farmasi, Fakultas Matematika dan Ilmu Pengetahuan Alam, Universitas Udayana Jalan Kampus Unud-Jimbaran, Jimbaran-Bali, Indonesia 80364. Pada kondisi kanker kolorektal terjadi overkekspresi COX-2 dan penghambatan Caspase-3 yang menyebabkan daya survival sel kanker meningkat karena terhambatnya mekanisme apoptosis. Kuersetin merupakan salah satu senyawa flavonoid yang diketahui memiliki aktivitas sebagai antitumor dan teruji secara in vitro dapat menginduksi terjadinya apoptosis pada sel kanker kolorektal WiDr. Tujuan dari penelitian ini adalah untuk mengetahui afinitas dan mekanisme senyawa kuersetin terhadap protein target COX-2 dan Caspase-3 sebagai antikanker kolorektal secara in silico dengan molecular docking. Hasil docking dinilai dari energi ikatan dan ikatan hidrogen yang dihasilkan antara kuersetin dengan protein. Semakin kecil nilai energi ikatan maka ikatan antara kuersetin dengan protein semakin kuat dan stabil. Hasil penelitian menunjukan bahwa kuersetin memiliki aktivitas sebagai antikanker kolorektal karena mampu menghambat protein COX-2 serta menginduksi Caspase-3 dengan nilai energi ikatan masing-masing yakni -9.54 dan -4.59. Hasil tersebut memperlihatkan bahwa kuersetin berpotensi menginduksi apoptosis pada kanker kolorektal
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
